Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum

Nature Immunology

Volumn 9, Issue 8, 2008, Pages 937-944

  Blanchard, Nicolas ^a   Gonzalez, Federico ^a   Schaeffer, Marie ^a   Joncker, Nathalie T ^a   Cheng, Tiffany ^a   Shastri, Anjali J ^a   Robey, Ellen A ^a   Shastri, Nilabh ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PARASITE ANTIGEN; PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CELL VACUOLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GENE; HOST; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, PROTOZOAN; ENDOPLASMIC RETICULUM; HISTOCOMPATIBILITY ANTIGENS CLASS I; LEUCYL AMINOPEPTIDASE; MICE; PROTOZOAN PROTEINS; TOXOPLASMA; TOXOPLASMOSIS; VACUOLES;

EID: 47849095938     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1629     Document Type: Article

References (49)

1. Montoya, J.G. & Liesenfeld, O. Toxoplasmosis. Lancet 363, 1965-1976 (2004).
2. Yap, G.S. & Sher, A. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Immunobiology 201 240-247 (1999).
3. Gazzinelli, R.T., Eltoum, I., Wynn, T.A. & Sher, A. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J. Immunol. 151, 3672-3681 (1993).
4. Schluter, D. et al. Both lymphotoxin-α and TNF are crucial for control of Toxoplasma gondii in the central nervous system. J. Immunol. 170, 6172-6182 (2003).
5. Suzuki, Y., Orellana, M.A., Schreiber, R.D. & Remington, J.S. Interferon-γ: The major mediator of resistance against Taxoplasma gondii. Science 240, 516-518 (1988).
6. Goldszmid, R.S. et al. TAP-1 indirectly regulates CD4+ T cell priming in Toxoplasma gondii infection by controlling NK cell IFN-γ production. J. Exp. Med. 204, 2591-2602 (2007).
7. Khan, I.A. et al. CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathog. 2, e49 (2006).
8. Lutjen, S., Soltek, S., Virna, S., Deckert, M. & Schluter, D. Organ- and disease-stage-specific regulation of Toxoplasma gondii-specific CD8-T-cell responses by CD4 T cells. Infect. Immun. 74, 5790-5801 (2006).
9. Buzoni-Gatel, D., Lepage, A.C., Dimier-Poisson, I.H., Bout, D.T. & Kasper, L.H. Adoptive transfer of gut intraepithelial lymphocytes protects against murine infection with Toxoplasma gondii. J. Immunol. 158, 5883-5889 (1997).
10. + T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J. Immunol. 146, 286-292 (1991).
11. + T cells in mice. J. Immunol. 140, 3943-3946 (1988).
12. + T cells are Ile major lymphocyte subpopulation involved in the protective immune response to Toxoplasmar gondii in mice. Clin. Exp. Immunol. 94, 207-212 (1991).
13. Brown, C.R. et al. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology 85, 419-428 (1995).
14. Hammer, G.E., Kanaseki, T. & Shastri, N. The final touches make perfect the peptide-MHC class I repertoire. Immunity 26, 397-406 (2007).
15. Blanchard, N. & Shastri, N. Coping with loss of perfection in the MHC class I peptide repertoire. Curr. Opin. Immunol. 20, 82-88 (2008).
16. Hammer, G.E., Gonzalez, F., Champsaur, M., Cado, D. & Shastri, N. The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules. Nat. Immunol. 7 103-112 (2006).
17. Yan, J. et al. In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class la and class lb molecules. J. Exp. Med. 203, 647-659 (2006).
18. Firat, E. et al. The role of endoplasmic reticulum-associated aminopeptidase 1 in immunity to infection and in cross-presentation. J. Immunol. 178, 2241-2248 (2007).
19. York, I.A., Brehm, M.A., Zendzian, S., Towne, C.F. & Rock, K.L. Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance. Proc, Natl. Acad. Sci. USA 103, 9202-9207 (2006).
20. Hammer, G.E., Gonzalez, F., James, E., Nolla, H. & Shastri, N. In the absence of ERAAP, the MHC class I molecules present many unstable and highly immunogenic peptides. Nat. Immunol. 8, 101-108 (2007).
21. Karttunen, J., Sanderson, S. & Shastri, N. Detection of rare antigen presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc. Natl. Acad. Sci. USA 89, 6020-6024 (1992).
22. + T cell clone protects against acute Toxoplasma gondii infection in mice. J. Immunol. 152, 1856-1860 (1994).
23. Kim, S.K. & Boothroyd, J.C. Stage-specific expression of surface antigens by Toxoplasma gondii as a mechanism to facilitate parasite persistence. J. Immunol. 174, 8038-8048 (2005).
24. Sanderson, S. & Shastri, N. LacZ inducible peptide/MHC specific T-hybrids. Int. Immunol. 6, 369-376 (1994).
25. Mendoza, L., Malarkannan, S. & Shastri, N. in Methods in Molecular Biology. Antigen Processing and Presentation Protocols Vol. 156 (ed. Solheim, J.C.) 255-264 (Humana Press, Totowa, NJ, 2000).
26. Lecordier, L. et al. Characterization of a dense granule antigen of Toxoplasma gondii (GRA6) associated to the network of the parasitophorous; vacuole. Mol. Biochem. Parasitol. 70, 85-94 (1995).
27. Mercier, C. et al. Biogenesis of nanotubular network in Toxoplasma parasitophorous vacuole induced by parasite proteins. Mol. Biol. Cell 13, 2397-2409 (2002).
28. Rammensee, H., Bachmann, J., Emmerich, N.P., Bachor, O.A. & Stevanovic, S. SYFPEITHI: Database for MHC ligands and peptide motifs. Immunogenetics 50, 213-219 (1999).
29. Kunisawa, J. & Shastri, N. Hsp90α chaperones large proteolytic intermediates in the MHC class I antigen processing pathway. Immunity 24, 523-534 (2006).
30. Kwok, L.Y. et al. The induction and kinetics of antigen-specific CD8 T cells are defined by the stage specificity and compartmentalization of the antigen in murine toxoplasmosis. J. Immunol. 170, 1949-1957 (2003).
31. Gajria, B. et al. ToxoDB: An integrated Toxoplasma gondii database resource. Nucleic Acids Res. 36, D553-D556 (2008).
32. Kong, J.T., Grigg, M.E., Uyetake, L., Parmley, S. & Boothroyd, J.C. Serotyping of Toxoplasma gondii infections in humans using synthetic peptides. J. Infect. Dis. 187, 1484-1495 (2003).
33. Gubbels, M.J., Striepen, B., Shastri, N., Turkoz, M. & Robey, E.A. Class I major histocompatibility complex presentation of antigens that escape from the parasitophorous vacuole of Toxoplasma gondii. Infect. Immun. 73, 703-711 (2005).
34. Dzierszinski, F. et al. Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells. Infect. Immun. 75, 5200-5209 (2007).
35. + T cell responses against Plasmodium liver stages in mice. Int. J. Parasitol. 34, 1529-1534 (2004).
36. Kumar, K.A. et al. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 444, 937-940 (2006).
37. + T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog. 2, e77 (2006).
38. Munks, M.W. et al. Genome-wide analysis reveals a highly diverse CD8 T cell response to murine cytomegalovirus. J. Immunol. 176 3760-3766 (2006).
39. Cesbron-Delauw, M.F., Gendrin, C., Travier, L., Ruffiot, P. & Mercier, C. Apicomplexa in mammalian cells: Trafficking to the parasitophorous vacuole. Traffic 9, 657-664 (2008).
40. Hakansson, S., Charron, A.J. & Sibley, L.D. Toxoplasma evacuoles: A two-step process of secretion and fusion forms the parasitophorous vacuole. EMBO J. 20, 3132-3144 (2001).
41. Taylor, S. et al. A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science 314, 1776-1780 (2006).
42. Saeij, J.P. et al. Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 314, 1780-1783 (2006).
43. Gilbert, L.A., Ravindran, S., Turetzky, J.M., Boothroyd, J.C. & Bradley, P.J. Toxoplasma gondii targets a protein phosphatase 2C to the nuclei of infected host cells. Eukaryot. Cell 6, 73-83 (2007).
44. Ravindran, S. & Boothroyd, J.C. Secretion of proteins into host cells by Apicomplexan parasites. Traffic 9, 647-656 (2008).
45. Shastri, N., Cardinaud, S., Schwab, S.R., Serwold, T. & Kunisawa, J. All the peptides that fit: The beginning, the middle, and the end of the MHC class I antigen-processing pathway. Immunol. Rev. 207, 31-41 (2005).
46. Serwold, T., Gonzalez, F., Kim, J., Jacob, R. & Shastri, N. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419, 480-483 (2002).
47. Reichmann, G., Villegas, E.N., Craig, L., Peach, R. & Hunter, CA. The CD28/B7 interaction is not required for resistance to Toxoplasma gondii in the brain but contributes to the development of immunopathology. J. Immunol. 163, 3354-3362 (1999).
48. Kirisits, M.J., Mui, E. & McLeod, R. Measurement of the efficacy of vaccines and antimicrobial therapy against infection with Toxoplasma gondii. Int. J. Parasitol. 30, 149-155 (2000).
49. Levy, F., Johnsson, N., Rumenapf, T. & Varshavsky, A. Using ubiquitin to follow the metabolic fate of a protein. Proc. Natl. Acad. Sci. USA 93, 4907-4912 (1996).